These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

412 related items for PubMed ID: 12697936

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer's disease.
    Donovan MH, Yazdani U, Norris RD, Games D, German DC, Eisch AJ.
    J Comp Neurol; 2006 Mar 01; 495(1):70-83. PubMed ID: 16432899
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Use of multimetric statistical analysis to characterize and discriminate between the performance of four Alzheimer's transgenic mouse lines differing in Abeta deposition.
    Leighty RE, Nilsson LN, Potter H, Costa DA, Low MA, Bales KR, Paul SM, Arendash GW.
    Behav Brain Res; 2004 Aug 12; 153(1):107-21. PubMed ID: 15219712
    [Abstract] [Full Text] [Related]

  • 8. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.
    Pihlaja R, Koistinaho J, Malm T, Sikkilä H, Vainio S, Koistinaho M.
    Glia; 2008 Jan 15; 56(2):154-63. PubMed ID: 18004725
    [Abstract] [Full Text] [Related]

  • 9. Traumatic brain injury in young, amyloid-beta peptide overexpressing transgenic mice induces marked ipsilateral hippocampal atrophy and diminished Abeta deposition during aging.
    Nakagawa Y, Nakamura M, McIntosh TK, Rodriguez A, Berlin JA, Smith DH, Saatman KE, Raghupathi R, Clemens J, Saido TC, Schmidt ML, Lee VM, Trojanowski JQ.
    J Comp Neurol; 1999 Aug 30; 411(3):390-8. PubMed ID: 10413774
    [Abstract] [Full Text] [Related]

  • 10. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease.
    Aucoin JS, Jiang P, Aznavour N, Tong XK, Buttini M, Descarries L, Hamel E.
    Neuroscience; 2005 Aug 30; 132(1):73-86. PubMed ID: 15780468
    [Abstract] [Full Text] [Related]

  • 11. Selective deposition of amyloid-beta protein in the entorhinal-dentate projection of a transgenic mouse model of Alzheimer's disease.
    Su Y, Ni B.
    J Neurosci Res; 1998 Jul 15; 53(2):177-86. PubMed ID: 9671974
    [Abstract] [Full Text] [Related]

  • 12. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.
    Savonenko A, Xu GM, Melnikova T, Morton JL, Gonzales V, Wong MP, Price DL, Tang F, Markowska AL, Borchelt DR.
    Neurobiol Dis; 2005 Apr 15; 18(3):602-17. PubMed ID: 15755686
    [Abstract] [Full Text] [Related]

  • 13. Inflammation occurs early during the Abeta deposition process in TgCRND8 mice.
    Dudal S, Krzywkowski P, Paquette J, Morissette C, Lacombe D, Tremblay P, Gervais F.
    Neurobiol Aging; 2004 Aug 15; 25(7):861-71. PubMed ID: 15212840
    [Abstract] [Full Text] [Related]

  • 14. Metallothionein-I and -III expression in animal models of Alzheimer disease.
    Carrasco J, Adlard P, Cotman C, Quintana A, Penkowa M, Xu F, Van Nostrand WE, Hidalgo J.
    Neuroscience; 2006 Dec 28; 143(4):911-22. PubMed ID: 17027170
    [Abstract] [Full Text] [Related]

  • 15. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
    Güntert A, Döbeli H, Bohrmann B.
    Neuroscience; 2006 Dec 01; 143(2):461-75. PubMed ID: 17008022
    [Abstract] [Full Text] [Related]

  • 16. Cognitive correlates of Abeta deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes.
    Howlett DR, Richardson JC, Austin A, Parsons AA, Bate ST, Davies DC, Gonzalez MI.
    Brain Res; 2004 Aug 13; 1017(1-2):130-6. PubMed ID: 15261108
    [Abstract] [Full Text] [Related]

  • 17. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.
    Sipos E, Kurunczi A, Kasza A, Horváth J, Felszeghy K, Laroche S, Toldi J, Párducz A, Penke B, Penke Z.
    Neuroscience; 2007 Jun 15; 147(1):28-36. PubMed ID: 17499931
    [Abstract] [Full Text] [Related]

  • 18. Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease.
    DeMattos RB, Bales KR, Cummins DJ, Paul SM, Holtzman DM.
    Science; 2002 Mar 22; 295(5563):2264-7. PubMed ID: 11910111
    [Abstract] [Full Text] [Related]

  • 19. Quantitative MRI reveals aging-associated T2 changes in mouse models of Alzheimer's disease.
    Falangola MF, Dyakin VV, Lee SP, Bogart A, Babb JS, Duff K, Nixon R, Helpern JA.
    NMR Biomed; 2007 May 22; 20(3):343-51. PubMed ID: 17451178
    [Abstract] [Full Text] [Related]

  • 20. Reversal of amyloid beta toxicity in Alzheimer's disease model Tg2576 by intraventricular antiamyloid beta antibody.
    Chauhan NB, Siegel GJ.
    J Neurosci Res; 2002 Jul 01; 69(1):10-23. PubMed ID: 12111811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.